Article Details
Retrieved on: 2024-08-09 13:13:35
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses the growth of the In Vitro Diagnostics (IVD) market, driven notably by COVID-19 demands, personalized medicine, and advancements in biotechnology and molecular diagnostics. Key players like Qiagen and Thermo Fisher Scientific are highlighted, with regulatory support under EU 2017/746 facilitating rapid deployment. Tags such as 'Medical tests,' 'Point-of-care testing,' and 'Laboratory developed test' underscore the diverse applications and technological innovations in this sector.
Article found on: media.market.us
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here